{'fraction_non_alphanumeric': 0.02412280701754386, 'fraction_numerical': 0.0043859649122807015, 'mean_word_length': 5.436619718309859, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Obstructive sleep apnoea in psoriasis and hidradenitis suppurativa

Obstructive sleep apnoea (OSA) is an independent risk factor for the development of cardiovascular disease. Epidemiological studies report that the prevalence of OSA in psoriasis patients (1) and in hidradenitis suppurativa (HS) patients is higher than healthy control populations. (2) This is the first prospective study to use formal sleep studies to assess the prevalence of OSA in HS.